How many insider declarations does Lixte Biotechnology Holdings, INC. have?

Lixte Biotechnology Holdings, INC. has filed 1 insider declaration with SEC (Form 4).

Who is the top reporting insider at Lixte Biotechnology Holdings, INC.?

The top reporting insider at Lixte Biotechnology Holdings, INC. is FORMAN ERIC, based on the count of public filings.

What is the net insider buy vs sell volume on Lixte Biotechnology Holdings, INC.?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

Lixte Biotechnology Holdings, INC.: directors' dealings · United States · SEC (Form 4)

SEC:lixte-biotechnology-holdings-inc-8e1100US·SEC (Form 4)Mcap 57M€Healthcare

AMF ↗

Explore the full management transaction log of Lixte Biotechnology Holdings, INC., a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Healthcare sector, Lixte Biotechnology Holdings, INC. has recorded 1 public disclosures. Market capitalisation: €57.2m. The latest transaction was filed on 6 April 2022 (Retenue fiscale). Among the most active insiders: FORMAN ERIC. Every trade is accessible without an account.

1

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

Analyst consensus

·

Valuation

P/Book5.5x

Beta1.05

Balance sheet & cash

Market cap57.2 M€

Debt / Equity9%

Profitability & ownership

ROE-102.0%

ROA-46.0%

% insiders4.5%

% institutions6.9%

Last declaration on 6 April 2022

All Executives1 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations